WPRIM Management System> DCMS> Acta Pharmaceutica Sinica B> 2015> 5> 3

Volume: 5 Issue: 3

1. Synthesis and antiviral activity of a series of novel N-phenylbenzamide and N-phenylacetophenone compounds as anti-HCV and anti-EV71 agents. Page:201—209
2. DZNep inhibits the proliferation of colon cancer HCT116 cells by inducing senescence and apoptosis. Page:188—193
3. Glucosylated caffeoylquinic acid derivatives from the flower buds of Lonicera japonica. Page:210—214
4. Acetylenes and fatty acids from Codonopsis pilosula. Page:215—222
5. Effects of antibiotic antitumor drugs on nucleotide levels in cultured tumor cells: an exploratory method to distinguish the mechanisms of antitumor drug action based on targeted metabolomics. Page:223—230
6. Development of a new ferulic acid certified reference material for use in clinical chemistry and pharmaceutical analysis. Page:231—237
7. Study on pharmacokinetics and tissue distribution of the isocorydine derivative (AICD) in rats by HPLC-DAD method. Page:238—245
8. Pharmacokinetic study of salvianolic acid D after oral and intravenous administration in rats. Page:246—253
9. Pharmacokinetic analysis and tissue distribution of Vam3 in the rat by a validated LC-MS/MS method. Page:254—263
10. Site-specific PEGylation of lidamycin and its antitumor activity. Page:264—269
11. Synchrotron radiation-based Fourier-transform infrared spectromicroscopy for characterization of the protein/peptide distribution in single microspheres. Page:270—276
12. Ginsenoside Rg1 protects against transient focal cerebral ischemic injury and suppresses its systemic metabolic changes in cerabral injury rats. Page:277—284
13. Nanocarrier-mediated co-delivery of chemotherapeutic drugs and gene agents for cancer treatment. Page:169—175
14. Antagonism of toll-like receptor 2 attenuates the formation and progression of abdominal aortic aneurysm. Page:176—187
15. Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis. Page:194—200